Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Abbreviations GLP-1: Glucagon-like peptide-1 GLP-1RA: Glucagon-like peptide-1 receptor agonist ITT: Intention-to-treat LEADER: Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results References Pernar CH, Ebot EM, Wilson KM, Mucci LA (2018) The epidemiology of prostate cancer
Hearts in White Coats is now available
3 Pharmacological mechanisms of tirzepatide and its applications in metabolic diseases Tirzepatide is a novel dual receptor agonist targeting both GLP-1 and GIP receptors
Eli Lilly has stated it "remains confident in the differentiated benefits of tirzepatide." Facing generic competition, Novo Nordisk has taken several steps: Launch of rebranded versions In December 2025, Health Canada approved two Novo Nordisk rebranded versions on December 22: These are identical to the branded versions but come in different packaging
US$ 29.72
US$ 23.22
US$ 24.29
US$ 24.64
